C. Weiss

发表

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials.

A. Hinke, C. Rödel, R. Sauer, 2010, International journal of radiation oncology, biology, physics.

Molecular targeted treatment and radiation therapy for rectal cancer

C. Rödel, F. Rödel, G. Capalbo, 2009, Strahlentherapie und Onkologie.

High Survivin Expression is Associated with Reduced Apoptosis in Rectal Cancer and May Predict Disease-Free Survival after Preoperative Radiochemotherapy and Surgical Resection

C. Rödel, F. Rödel, G. Grabenbauer, 2002, Strahlentherapie und Onkologie.

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

S. Koch, R. Cathomas, M. Fotin‐Mleczek, 2014, BMC Cancer.

Long‐Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High‐Risk Bladder Cancer (Ta, Tis, T1, T2)

A. Hartmann, B. Wullich, W. Uter, 2019, The oncologist.

Neoadjuvant chemoradiation versus perioperative chemotherapy followed by surgery in resectable adenocarcinomas of the esophagogastric junction: A retrospective single center analysis

J. Trojan, W. Bechstein, C. Rödel, 2013, Oncology letters.

The Role of Radiotherapy in the Multimodal Management of Esophageal Cancer

C. Rödel, E. Fokas, C. Weiss, 2013, Digestive Diseases.

Unusual acute and delayed skin reactions during and after whole-brain radiotherapy in combination with the BRAF inhibitor vemurafenib

C. Rödel, M. Meissner, M. Wolter, 2014, Strahlentherapie und Onkologie.

Tumor-infiltrating lymphocytes favor the response to chemoradiotherapy of head and neck cancer

C. Rödel, E. Fokas, F. Rödel, 2014, Oncoimmunology.

Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences

S. Ghanaati, C. Rödel, E. Fokas, 2014, British Journal of Cancer.

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer

C. Rödel, E. Fokas, F. Rödel, 2013, British Journal of Cancer.

[Radiochemotherapeutic options for bladder cancer].

C. Rödel, R. Sauer, C. Weiss, 2008, Aktuelle Urologie.

Combined-Modality Treatment and Organ Preservation in Bladder Cancer

C. Rödel, F. Rödel, T. Papadopoulos, 2005, Strahlentherapie und Onkologie.

Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy

L. Häberle, B. Wullich, C. Rödel, 2013, World Journal of Urology.

RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial

J. Debus, C. Belka, C. Rödel, 2020, Clinical and translational radiation oncology.

Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 study.

T. Beißbarth, J. Rüschoff, C. Rödel, 2013, International journal of radiation oncology, biology, physics.

Caveolin-1 as a prognostic marker for local control after preoperative chemoradiation therapy in rectal cancer.

C. Rödel, F. Rödel, G. Capalbo, 2009, International journal of radiation oncology, biology, physics.

To combine or not combine: the role of radiotherapy and targeted agents in the treatment for renal cell carcinoma

C. Rödel, C. Weiss, B. Schulze, 2014, World Journal of Urology.

Urological cancer: Chemoradiation superior in muscle-invasive bladder cancer

C. Rödel, C. Weiss, 2012, Nature Reviews Clinical Oncology.

Radiation-induced survivin nuclear accumulation is linked to DNA damage repair.

K. Dittmann, C. Rödel, F. Rödel, 2010, International journal of radiation oncology, biology, physics.

Surgical oncology: Alternatives to surgery after failure of instillation therapy

C. Rödel, C. Weiss, 2010, Nature Reviews Clinical Oncology.

Neuropilin‐2 and its ligand VEGF‐C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients

A. Hartmann, H. Taubert, S. Wach, 2015, International journal of cancer.

Patient- and Treatment-Related Risk Factors for Nausea and Emesis during Concurrent Chemoradiotherapy

C. Rödel, C. Weiss, Katharina Grau, 2010, Strahlentherapie und Onkologie.

Erratum to: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck

S. Ghanaati, C. Rödel, F. Rödel, 2015, Strahlentherapie und Onkologie.

Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck

S. Ghanaati, C. Rödel, F. Rödel, 2015, Strahlentherapie und Onkologie.

Reirradiation with cetuximab in locoregional recurrent and inoperable squamous cell carcinoma of the head and neck: feasibility and first efficacy results.

C. Rödel, M. Hambek, Christian Keller, 2012, International journal of radiation oncology, biology, physics.

Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck

T. Stöver, C. Rödel, E. Fokas, 2014, Strahlentherapie und Onkologie.

Multimodale Therapien zum Blasenerhalt bei High-grade-Blasentumoren

B. Wullich, R. Fietkau, C. Weiss, 2008, Der Urologe.

Trimodality treatment and selective organ preservation for bladder cancer.

C. Rödel, R. Sauer, C. Weiss, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Organ preservation by combined modality treatment in bladder cancer: the European perspective.

C. Rödel, R. Sauer, C. Weiss, 2005, Seminars in radiation oncology.

Combined-Modality Treatment for Anal Cancer

C. Rödel, C. Weiss, I. Fraunholz, 2010, Strahlentherapie und Onkologie.

Activator protein 1 shows a biphasic induction and transcriptional activity after low dose X-irradiation in EA.hy.926 endothelial cells

C. Rödel, F. Rödel, R. Voll, 2009, Autoimmunity.

Combined Effect of Tumor Necrosis Factor-alpha and Ionizing Radiation on the Induction of Apoptosis in 5637 Bladder Carcinoma Cells

C. Rödel, F. Rödel, R. Sauer, 2006, Strahlentherapie und Onkologie.

15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment.

L. Häberle, B. Wullich, C. Rödel, 2011, Anticancer research.

Study of the anti-inflammatory effects of low-dose radiation

S. Hehlgans, C. Rödel, F. Rödel, 2015, Strahlentherapie und Onkologie.

Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma.

K. Franz, C. Rödel, J. Steinbach, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Pretreatment Proliferation and Local Control in Bladder Cancer after Radiotherapy with or without Concurrent Chemotherapy

C. Rödel, F. Rödel, T. Papadopoulos, 2007, Strahlentherapie und Onkologie.

Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer.

J. Dunst, C. Rödel, T. Papadopoulos, 2007, International journal of radiation oncology, biology, physics.

Organ-sparing multimodality treatment for muscle-invasive bladder cancer: can we continue to ignore the evidence?

C. Rödel, C. Weiss, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?

J. Dunst, C. Rödel, R. Sauer, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

S. Koch, R. Cathomas, M. Fotin‐Mleczek, 2019, Journal of Immunotherapy for Cancer.

Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.

C. Rödel, K. Eberlein, A. Haberl, 2010, International journal of radiation oncology, biology, physics.

Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?

C. Rödel, A. Haberl, C. Weiss, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Multimodal therapy for bladder sparing with high grade bladder tumors].

B. Wullich, R. Fietkau, P. Goebell, 2008, Der Urologe. Ausg. A.

Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models.

Benjamin Frey, Christian Weiss, Claus Rödel, 2008, International journal of radiation oncology, biology, physics.

Treatment Options for High-Risk T1 Bladder Cancer

C. Rödel, R. Sauer, R. Fietkau, 2008, Strahlentherapie und Onkologie.

Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.

J. Dunst, C. Rödel, R. Sauer, 2008, International journal of radiation oncology, biology, physics.

Status Quo and Future Perspectives of Radiochemotherapy

C. Rödel, R. Sauer, R. Fietkau, 2008 .

Vogel Treatment Options for High-Risk T 1 Bladder Cancer Status Quo and Future Perspectives of Radiochemotherapy

C. Rödel, R. Sauer, R. Fietkau, 2008 .

Combined Systemic Therapy and Radiotherapy for Bladder Cancer

C. Rödel, R. Sauer, C. Weiss, 2007, Strahlentherapie und Onkologie.

Radiochemotherapy for bladder cancer.

C. Rödel, R. Sauer, R. Fietkau, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiochemotherapy with temozolomide for patients with glioblastoma

K. Franz, V. Seifert, C. Rödel, 2011, Strahlentherapie und Onkologie.

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

J. Chang-Claude, A. Dunning, R. Stock, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Significant Increase in Residual DNA Damage as a Possible Mechanism of Radiosensitization by Gemcitabine

G. Grabenbauer, R. Sauer, L. Distel, 2003, Strahlentherapie und Onkologie.

Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy

R. Wirtz, C. Rödel, E. Fokas, 2015, International journal of cancer.

Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy.

C. Rödel, F. Rödel, R. Sauer, 2009, International journal of radiation oncology, biology, physics.

Combined Cetuximab and Reirradiation for Locoregional Recurrent and Inoperable Squamous Cell Carcinoma of the Head and Neck

C. Rödel, M. Hambek, P. Balermpas, 2009, Strahlentherapie und Onkologie.

Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia.

Rainer Fietkau, Christian Weiss, C. Rödel, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer

C. Rödel, E. Fokas, F. Rödel, 2014, British Journal of Cancer.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.